New Test Predicts Effectiveness of CGRP Drugs for Migraine
Social support benefits individuals prone to depression under stress
Consideration, Compassion, Kindness, and Empathy
How to Keep Your Mind Sharp: What Research Says About Preventing Dementia
5 Effective Ways to Improve Concentration and Cognition
Mushroom Extract Shown to Dramatically Improve Brain-Cell Growth in The Lab
Discovery of a New Brain Disease in Children Could Help Us Understand Dementia
Human Organoids for Brain Regeneration
Brain and behaviour: understanding the neural effects of cannabis
These mushrooms might magnify memory
Novel Resuscitation for Patients With Nonshockable Rhythms in Cardiac Arrest
TMS Tied to ‘Marked’ Antidepressant, Anxiolytic Effects in Anxious Depression
Infants Exposed to Excessive Screen Time Show Differences in Brain Function Beyond Eight Years of Age
Brain MRIs reveal impact of ‘toxic stress’ on Black children
Music Improves Quality of Life for Patients With Dementia
New study finds 6 ways to slow memory decline and lower dementia risk
Psychiatric Illnesses Share Common Brain Network
Surprising Discovery: MIT Neuroscientists Find That Adult Brain Is Filled With Millions of “Silent Synapses”
Six minutes of high-intensity exercise vital for brain health, study says
FDA approves Alzheimer’s drug shown to moderately slow cognitive decline in early stages of the disease
https://www.statnews.com/2023/01/06/fda-approves-alzheimers-drug-leqembi-eisai/?utm_source=STAT+Newsletters&utm_campaign=68b2f02896-breaking_COPY_04&utm_medium=email&utm_term=0_8cab1d7961-68b2f02896-151973709 Continue reading FDA approves Alzheimer’s drug shown to moderately slow cognitive decline in early stages of the disease

You must be logged in to post a comment.